Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Advances in the Understanding of Etiology (I)
-
1. Infection and autoimmunity: a two-way relationship
- Dr. Ricard Cervera
-
2. Autoimmunity and atherosclerosis
- Prof. Johan Frostegard
-
3. Endothelium and autoimmunity
- Prof. Pier Luigi Meroni
- Advances in the Understanding of Etiology (II)
-
4. Prolactin has a pathogenic role in systemic lupus erythematosus
- Prof. Luis Jara-Quezada
-
5. Sjögren's syndrome: current knowledge and future prospects
- Prof. Athanasios G. Tzioufas
-
6. Genetic and environmental triggers of autoimmune thyroid diseases
- Prof. Yaron Tomer
- Advances in Pathogenesis and Clinical Manifestation
-
8. Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes
- Dr. Luís Eduardo Coelho Andrade
-
9. Pathogenic mechanisms of autoantibodies: antibodies to intracellular and membrane-bound antigens
- Dr. Luís Eduardo Coelho Andrade
-
10. What causes primary biliary cholangitis?
- Dr. M. Eric Gershwin
-
11. Capillaroscopy in autoimmune rheumatic diseases
- Prof. Maurizio Cutolo
- Advances in Diagnostic Methodologies (I)
-
12. The past, present & future of ANA testing: history and challenges of ANA
- Prof. Marvin J. Fritzler
-
13. The past, present & future of ANA testing: changing bandwidth and future of ANA
- Prof. Marvin J. Fritzler
-
14. Diagnostic methods in autoimmunity
- Mr. Steven Binder
-
15. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
16. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 2
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
17. Novel aspects of systemic sclerosis
- Prof. Gabriele Valentini
- Advances in Diagnostic Methodologies (II)
-
18. An update on the multiple faces of celiac disease
- Prof. Aaron Lerner
-
19. Protective autoantibodies
- Prof. Elias Toubi
-
21. Rheumatic fever: a model of a post-infectious autoimmune disease
- Prof. Jorge Kalil
- Treatments of autoimmune diseases
-
22. Intravenous immunoglobulins: clinical evidence
- Prof. Shaye Kivity
- Latest Developments in the Field
-
23. Adjuvants and autoimmunity
- Dr. Eitan Israeli
-
24. Antiphospholipid syndrome (APS): from pathogenesis to treatment
- Prof. Roger Levy
-
25. Vitamin D and autoimmunity
- Dr. Shir Azrielant
-
26. Pregnancy in rheumatic diseases
- Prof. Pier Luigi Meroni
- Archived Lectures *These may not cover the latest advances in the field
-
27. Pathogenic mechanisms of autoantibodies
- Prof. Cees Kallenberg
-
28. B lymphocytes on the frontline of autoimmunity
- Prof. Pierre Youinou
-
29. Apoptotic cell clearance deficiency
- Prof. Martin Herrmann
-
30. Auto-antibodies as predictors of autoimmune disease
- Dr. Nicola Bizzaro
-
31. Innate immunity and natural autoantibodies
- Prof. Luc Mouthon
-
32. Accelerated atherosclerosis in autoimmune rheumatic disease
- Dr. Andrea Doria
-
33. Pregnancy in autoimmune rheumatic diseases
- Prof. Angela Tincani
-
36. Immunologic mechanisms in systemic lupus erythematosus
- Prof. Kok-Yong Fong
-
37. Osteoimmunology
- Prof. João Eurico Fonseca
- Ms. Joana Caetano-Lopes
-
38. ANCA-associated systemic vasculitides
- Prof. Loic Guillevin
-
39. The common origin for diverse autoimmune diseases
- Prof. Juan-Manuel Anaya
-
40. Anti-cytokine therapy in rheumatoid arthritis
- Prof. Piercarlo Sarzi-Puttini
-
41. Sjogren's syndrome: autoimmune epithelitis
- Prof. Haralampos Moutsopoulos
-
42. Vitamin D and autoimmunity
- Dr. Howard Amital
-
43. Intravenous immunoglobulins: myth and reality
- Prof. Zera Tellier
Printable Handouts
Navigable Slide Index
- Introduction
- Gluten
- Celiac disease (CD)
- Gluten structure
- CD - damaged small intestine lining
- The four degrees of intestinal atrophy in CD
- Genetic basis of CD
- Prevalence of celiac disease
- Reasons for the increased incidence of CD
- Clinical presentations
- Multiple clinical presentations of celiac disease
- Historical photo of celiac child
- The celiac iceberg
- Pathogenesis
- Adverse effects of gluten
- CD pathogenesis
- Food additive breach intestinal permeability
- The HLA-DQ 2/8 grove
- Proinflammatory trigger
- Anti endomysial antibody: marker of CD
- Other serological markers of CD
- Decision flowchart: diagnostic evaluation of CD
- Summary – antibodies in CD
- Sera immunoreactivity of neo-epitopes
- Antibodies’ activity and intestinal damage
- Sensitivity and specificity of CD biomarkers
- High risk groups who should be screened
- The importance of early diagnosis
- Cumulative risk of other autoimmune disease
- The difficulties to follow gluten-free diet
- New therapeutic strategies for CD
- Gluten dependent conditions
- Gluten dependent disease compared to IBS
- The debate continues…
- Cross linking capacities of the mTg
- Pathophysiological summary - tTg
- Pathophysiological summary - mTg
- CD take home messages
- Acknowledgements
Topics Covered
- Celiac disease as a multi-faced, gluten dependent, autoimmune disease
- Substantial change in epidemiology and clinical presentations in the last decades
- The growing list of environmental factors
- Microbial transglutaminase (mTg)
- Diagnostic biomarkers (EMA, tTg, DGP, neo-tTg, neo-mTg)
- Expansion of gluten dependent conditions
- The problem of gluten free diet compliance
- Impacting the environmental factors
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lerner, A. (2018, May 1). An update on the multiple faces of celiac disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 7, 2024, from https://doi.org/10.69645/KGTI1661.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Aaron Lerner has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
An update on the multiple faces of celiac disease
A selection of talks on Gastroenterology & Nephrology
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Professor Aaron Lerner.
I am a pediatrician,
specializes in Pediatric Gastroenterology and Nutrition,
and the Adult Gastroenterology.
Originally, I am from Israel,
from the Technion - Israel Institute of Technology.
But now, I am doing my research in the Aesku.Kipp Institute in Germany.
We are going to talk about some updates on the multiple faces of Celiac disease.
0:27
In fact, we are talking about a lot of products that contains
gluten and gluten is the main environmental inducer of Celiac disease.
But before starting, let's have a definition.
What is Celiac disease?
0:44
Celiac disease is an autoimmune disorder elicited on
genetically predisposed individuals that are consuming gluten-containing grains.
The gluten is the offending agent but
there are some other prolamins that the patients are not allowed to ingest.
I'm talking about wheat,
barley, rye, and oats.
Epidemiologically speaking, the incidence is one to two percent in the population.
However, there are some Nordic countries like Sweden, Norway,
Ireland, most of the Germany, Finland,
etc, where the incidence is above two percent.
In the last couple of years,
there were some observations that in the Sahara desert,
some tribes, they have
an increased incidence of Celiac disease amounting to six to seven percent.
This is most probably because of genetic inbreeding.
Their disease has some geographical ingredient.
It is much more in the Northern,
in the Western countries.
We are talking about life-long and gluten-dependent autoimmune condition.
Being auto-immune, there is always some genetic aspect to it.
But always, there are environmental factors and more and more,
we are discovering much more environmental factors.
Up 'til now, gluten is the causative.
However, many others associated environmental factors were suggested like infection,
be it viral or bacterial;
the age of the infant; the infant nutrition;
the amount and the type of gluten ingested during the first year of life;
early antibiotics in the first year of life;
microbiota or dysbiota ratio is most probably contributing to a lot of the disease;
and lately, the couple of publication about
industrial processed food additives that they may affect Celiac disease.
Of course nowadays, some modern
lifestyle can affect the disease like the amount of stress, etc.
Clinically speaking, there is epidemiological shift in the disease phenotype.
The disease is much more prevalent in the last three or four decades in advanced age,
and the clinical presentation is much more subtle.
We see more and more latent hypo-symptomatic or asymptomatic presentation.
We know also the evolutionary aspect of wheat might be important because during evolution,
I'm talking about the last 10,000 years,
the gluten content toxicity and immunogenicity is increasing in the wheat.